Singapura Finance Reports Full Year 2024 Financial Results
February 27, 2025 - 05:59
Singapura Finance has announced its financial results for the full year 2024, revealing a slight decline in earnings per share (EPS) at S$0.038, compared to S$0.039 in the previous fiscal year. Despite this decrease in EPS, the company demonstrated a positive trend in revenue, which rose to S$23.7 million, marking an increase of 8.5% from FY 2023.
The growth in revenue reflects the company's ongoing efforts to enhance its service offerings and expand its customer base. The financial results indicate a resilient performance amid challenging market conditions. Additionally, the company has been focusing on optimizing its operations to improve efficiency and profitability.
Looking ahead, Singapura Finance is optimistic about its growth prospects. The management is committed to implementing strategic initiatives aimed at sustaining revenue growth and enhancing shareholder value. This results announcement underscores the company's dedication to navigating the evolving financial landscape while maintaining a strong operational foundation.
MORE NEWS
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...